944396-07-0 Usage
Uses
Used in Oncology:
BKM120 (NVP-BKM120, Buparlisib) is used as an anti-tumor agent for the treatment of glioma cells. It specifically inhibits PI3 kinase, leading to cell death in these cancerous cells. This selective action makes it a promising therapeutic option for patients with brain or spinal tumors.
Additionally, Buparlisib has shown a significant reduction in DNA synthesis in a mouse model of BRCA1-linked triple-negative breast cancer, with minimal effects on normal tissue. This suggests its potential use in targeted cancer therapies for specific genetic mutations.
While the provided materials do not explicitly mention other industries, the primary focus of BKM120 (NVP-BKM120, Buparlisib) is in the field of oncology for its anti-tumor properties. Further research and development may reveal additional applications in different industries.
References
Burger et al. (2011), Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer; ACS Med. Chem. Lett. 2 774
Maira et al. (2012), Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor; Mol. Cancer Ther. 11 317
Brachmann et al. (2012), Characterization of the mechanism of action of the pan class I PI3K inhibitor NVP-BKM120 across a broad range of concentrations; Mol. Cancer Ther. 11 1747
Juvekar et al. (2016), Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletion; Proc. Natl. Acad. Sci USA. 113 E4338
Check Digit Verification of cas no
The CAS Registry Mumber 944396-07-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,4,3,9 and 6 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 944396-07:
(8*9)+(7*4)+(6*4)+(5*3)+(4*9)+(3*6)+(2*0)+(1*7)=200
200 % 10 = 0
So 944396-07-0 is a valid CAS Registry Number.